Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H23NO.C7H7ClN4O2 |
| Molecular Weight | 496.001 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(NC(Cl)=N2)C(=O)N(C)C1=O.CN3CCC(CC3)OC(C4=CC=CC=C4)C5=CC=CC=C5
InChI
InChIKey=JSNIFGPPGAINSG-UHFFFAOYSA-N
InChI=1S/C19H23NO.C7H7ClN4O2/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h2-11,18-19H,12-15H2,1H3;1-2H3,(H,9,10)
| Molecular Formula | C19H23NO |
| Molecular Weight | 281.392 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C7H7ClN4O2 |
| Molecular Weight | 214.609 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14238605 | https://www.ncbi.nlm.nih.gov/pubmed/14238604
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14238605 | https://www.ncbi.nlm.nih.gov/pubmed/14238604
Piprinhydrinate is compositon of Diphenylpyraline and 8-chloroteophylline. 8-Chlorotheophylline is a stimulant drug of the xanthine chemical class, with physiological effects similar to caffeine. Diphenylpyraline is an antihistamine that prevents, but does not reverse, responses mediated by histamine alone. Diphenylpyraline antagonizes most of the pharmacological effects of histamine, including urticaria and pruritus. Also, diphenylpyraline may exhibit anticholinergic actions (as do most of the antihistamines) and may thus provide a drying effect on the nasal mucosa. 8-Chlorotheophylline main use is in combination with Diphenylpyraline or diphenhydramine in the antiemetic Piprinhydrinate and dimenhydrinate. Diphenylpyraline (or diphenhydramine) reduces nausea but causes drowsiness, and the stimulant properties of 8-Chlorotheophylline help ward off that side-effect.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1912125 |
4.1 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1912125
Brain tissue was obtained at autopsy on 18 Japanese patients with chronic schizophrenia. The brain tissues were weighed, homogenized and centrifuged. The specific 3H-mepyramine binding to the brain tissues reached equilibrium values within 20 min after incubation at 25°C. Inhibition of the specific component of the 3H-mepyramine binding by Diphenylpyraline was then studied. The H1 antagonist diphenylpyraline (Ki=4.1nM) was potent competitors for the specific binding of 3H-mepyramine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:52:18 GMT 2025
by
admin
on
Wed Apr 02 08:52:18 GMT 2025
|
| Record UNII |
SI78RFJ7XI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000082219
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
m4640
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
830
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
SUB09886MIG
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
C66408
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
SI78RFJ7XI
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
DTXSID80209413
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
606-90-6
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL1492
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
210-128-0
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY | |||
|
71640
Created by
admin on Wed Apr 02 08:52:18 GMT 2025 , Edited by admin on Wed Apr 02 08:52:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |